TriMas (TRS) Expected to Announce Earnings on Thursday

TriMas (NASDAQ:TRS) is expected to be posting its Q4 2025 results before the market opens on Thursday, February 26th. Analysts expect TriMas to post earnings of $0.41 per share and revenue of $192.9560 million for the quarter. Investors can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Thursday, February 26, 2026 at 10:00 AM ET.

TriMas Stock Performance

Shares of NASDAQ TRS opened at $36.40 on Wednesday. TriMas has a 12 month low of $19.33 and a 12 month high of $40.34. The company has a quick ratio of 1.42, a current ratio of 2.68 and a debt-to-equity ratio of 0.56. The company has a market cap of $1.48 billion, a P/E ratio of 33.70 and a beta of 0.57. The business’s 50 day moving average is $35.41 and its two-hundred day moving average is $35.95.

TriMas Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, March 6th. Investors of record on Friday, February 27th will be paid a dividend of $0.04 per share. This represents a $0.16 annualized dividend and a yield of 0.4%. The ex-dividend date is Friday, February 27th. TriMas’s dividend payout ratio is presently 14.81%.

Analyst Ratings Changes

TRS has been the subject of a number of research reports. Weiss Ratings reissued a “hold (c+)” rating on shares of TriMas in a report on Monday, December 29th. KeyCorp cut their price objective on shares of TriMas from $45.00 to $38.00 and set an “overweight” rating for the company in a research report on Thursday, November 13th. Wall Street Zen downgraded TriMas from a “buy” rating to a “hold” rating in a research report on Saturday, December 6th. Zacks Research lowered TriMas from a “strong-buy” rating to a “hold” rating in a research note on Thursday, December 11th. Finally, BWS Financial reiterated a “buy” rating and issued a $45.00 price objective on shares of TriMas in a research report on Friday, December 5th. Two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, TriMas has a consensus rating of “Moderate Buy” and an average target price of $41.50.

Hedge Funds Weigh In On TriMas

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Aristeia Capital L.L.C. raised its stake in shares of TriMas by 129.1% in the fourth quarter. Aristeia Capital L.L.C. now owns 16,012 shares of the industrial products company’s stock valued at $568,000 after acquiring an additional 9,023 shares during the last quarter. Freestone Grove Partners LP bought a new stake in TriMas during the 4th quarter worth approximately $530,000. Jain Global LLC bought a new stake in TriMas during the 4th quarter worth approximately $521,000. Prelude Capital Management LLC acquired a new stake in TriMas during the 3rd quarter valued at $394,000. Finally, Beartown Capital Management LLC bought a new position in TriMas in the 4th quarter valued at $354,000. 99.42% of the stock is currently owned by institutional investors and hedge funds.

About TriMas

TriMas Corporation is a diversified industrial company headquartered in Bloomfield Hills, Michigan. Established in 1980, TriMas has built a global reputation for designing and manufacturing specialized products that serve a wide array of end markets. The company operates through multiple segments, each focused on high-demand niches where engineered solutions and rigorous quality standards are essential.

The Packaging segment supplies closures, dispensing systems and related components for the personal care, household chemicals, food and beverage, and pharmaceutical markets.